Advanced Cooling Therapy wins CE Mark for esophageal cooling device
Advanced Cooling Therapy said today that it won CE Mark approval in the European Union for use of its esophageal cooling device with Stryker‘s (NYSE:SYK) Altrix Precision Temperature Management System.
The Chicago-based company’s ECD is designed to modulate and control patient temperature using a single-use triple lumen system that is inserted into the patient’s esophagus. The device can be quickly inserted, like a standard gastric tube, and can control a patient’s temperature in a variety of clinical environments, including the operating room, emergency room and ICU.
Advanced Cooling Therapy said that it is the only product on the market approved to use the esophagus for temperature modulation.
“This new CE mark clearance addresses a significant need in a growing market, in which temperature management is increasingly important for both warming and cooling patients when clinically indicated,” international sales manager Markus Tödtling said in prepared remarks. “The ECD’s compatibility with a new line of control units, or heat exchangers, now available on the market, enables us to meet the growing needs of hospitals across Europe that are utilizing the Altrix Precision Temperature Management System in emergency departments, intensive care units, and operating rooms for a wide range of cooling and warming needs.”
“Because our existing product line is compatible with the majority of existing control units, the ECD is a...
Source: Mass Device - Category: Medical Equipment Authors: Sarah Faulkner Tags: Regulatory/Clearance Wall Street Beat Advanced Cooling Therapy Stryker Source Type: news
More News: Emergency Medicine | Environmental Health | Gastroenterology | Hospital Management | Hospitals | Hypothermia | Intensive Care